Erectile dysfunction

FA Yafi, L Jenkins, M Albersen, G Corona… - Nature reviews Disease …, 2016 - nature.com
Erectile dysfunction is a multidimensional but common male sexual dysfunction that involves
an alteration in any of the components of the erectile response, including organic, relational …

Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among US FDA approved pharmaceuticals: miniperspective

E Vitaku, DT Smith, JT Njardarson - Journal of medicinal chemistry, 2014 - ACS Publications
Nitrogen heterocycles are among the most significant structural components of
pharmaceuticals. Analysis of our database of US FDA approved drugs reveals that 59% of …

The Drug Repurposing Hub: a next-generation drug library and information resource

SM Corsello, JA Bittker, Z Liu, J Gould, P McCarren… - Nature medicine, 2017 - nature.com
CORRESPONDENCE (tool compounds are valuable for achieving the target redundancy
needed to differentiate on-target from off-target activities of clinical drugs being considered …

HINGRL: predicting drug–disease associations with graph representation learning on heterogeneous information networks

BW Zhao, L Hu, ZH You, L Wang… - Briefings in …, 2022 - academic.oup.com
Identifying new indications for drugs plays an essential role at many phases of drug
research and development. Computational methods are regarded as an effective way to …

Strategies to increase nitric oxide signalling in cardiovascular disease

JO Lundberg, MT Gladwin, E Weitzberg - Nature reviews Drug …, 2015 - nature.com
Nitric oxide (NO) is a key signalling molecule in the cardiovascular, immune and central
nervous systems, and crucial steps in the regulation of NO bioavailability in health and …

[HTML][HTML] Enhancing autophagy in Alzheimer's disease through drug repositioning

M Eshraghi, M Ahmadi, S Afshar, S Lorzadeh… - Pharmacology & …, 2022 - Elsevier
Alzheimer's disease (AD) is one of the biggest human health threats due to increases in
aging of the global population. Unfortunately, drugs for treating AD have been largely …

V Diretriz da Sociedade Brasileira de Cardiologia sobre tratamento do infarto agudo do miocárdio com supradesnível do segmento ST

LS Piegas, A Timerman, GS Feitosa… - Arquivos brasileiros de …, 2015 - SciELO Brasil
Material de distribuição exclusiva à classe médica. Os Arquivos Brasileiros de Cardiologia
não se responsabilizam pelo acesso indevido a seu conteúdo e que contrarie a …

Erectile dysfunction

R Shamloul, H Ghanem - The Lancet, 2013 - thelancet.com
Erectile dysfunction is a common clinical entity that affects mainly men older than 40 years.
In addition to the classical causes of erectile dysfunction, such as diabetes mellitus and …

PDE5 inhibitors–pharmacology and clinical applications 20 years after sildenafil discovery

KE Andersson - British journal of pharmacology, 2018 - Wiley Online Library
The discovery of the nitric oxide/cGMP pathway was the basis for our understanding of many
normal physiological functions and the pathophysiology of several diseases. Since the …

An overview of PDE4 inhibitors in clinical trials: 2010 to early 2022

L Crocetti, G Floresta, A Cilibrizzi, MP Giovannoni - Molecules, 2022 - mdpi.com
Since the early 1980s, phosphodiesterase 4 (PDE4) has been an attractive target for the
treatment of inflammation-based diseases. Several scientific advancements, by both …